United Therapeutics | UTHR - Market Capitalization


United Therapeutics reported $22.28B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amarin USD 341M 4M Sep/2025
Ardelyx USD 1.33B 390M Sep/2025
Baxter International USD 9.54B 279M Feb/2026
Bayer EUR 27.23B 2.14B Sep/2025
BioCryst Pharmaceuticals USD 1.23B 115M Dec/2023
Biogen USD 27.01B 1.19B Feb/2026
BioMarin Pharmaceutical USD 12.21B 1.81B Feb/2026
Emergent BioSolutions USD 125M 51M Dec/2023
Esperion Therapeutics USD 340M 235M Dec/2023
Gilead Sciences USD 183.59B 31.31B Feb/2026
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Halozyme Therapeutics USD 10.23B 2.31B Feb/2026
Insmed USD 23.91B 13.21B Feb/2026
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Lexicon Pharmaceuticals USD 267M 294M Sep/2023
Moderna USD 16.5B 6.41B Feb/2026
Omeros USD 184M 158M Sep/2023
Pfizer USD 152.89B 11.32B Feb/2026
PTC Therapeutics USD 5.36B 744M Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
United Therapeutics USD 18.96B 6B Sep/2025
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026